Vinorelbine, ifosfamide and cisplatin as first-line treatment in patients with inoperable non-small cell lung cancer.

[1]  P. Astoul,et al.  Cisplatin, ifosfamide, and vinorelbine combination chemotherapy in stage III-IV non-small-cell lung cancer: a phase II study. , 1998, American journal of clinical oncology.

[2]  J. Crowley,et al.  Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  DeVore,et al.  New Agents in the Management of Non-Small Cell Lung Cancer. , 1997, Cancer control : journal of the Moffitt Cancer Center.

[4]  T. Chevalier,et al.  The cost-effectiveness of navelbine alone or in combination with cisplatin in comparison to other chemotherapy regimens and best supportive care in stage IV non-small cell lung cancer. , 1996, European journal of cancer.

[5]  E. Partridge,et al.  Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group). , 1996, Seminars in oncology.

[6]  A. Chella,et al.  Phase II study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancer. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  P. Souquet,et al.  Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer. , 1996, Seminars in oncology.

[8]  J. Crawford.  Update: vinorelbine (navelbine) in non-small cell lung cancer. , 1996, Seminars in oncology.

[9]  F. Shepherd,et al.  Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study. , 1996, European journal of cancer.

[10]  L. Frontini,et al.  Cisplatin-Vinorelbine Combination Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer , 1996, Tumori.

[11]  E. Vokes,et al.  Should non-small cell carcinoma of the lung be treated with chemotherapy? Pro: chemotherapy is for non-small cell lung cancer. , 1995, American journal of respiratory and critical care medicine.

[12]  S Lippman,et al.  Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Y. Nishiwaki,et al.  A Phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer , 1994 .

[14]  J. Pujol,et al.  A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis. , 1994, Seminars in oncology.

[15]  F. Invernizzi,et al.  Chemotherapy vs supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literature. , 1994, Chest.

[16]  P Chomy,et al.  Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  A. Oxman,et al.  Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough? , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  S. Kaasa,et al.  Polychemotherapy in advanced non small cell lung cancer: a meta-analysis , 1993, The Lancet.

[19]  H. Bartelink,et al.  Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. , 1992, The New England journal of medicine.

[20]  N. Niederle,et al.  Ifosfamide in non-small cell lung cancer: a review. , 1992, Seminars in oncology.

[21]  K. Propert,et al.  A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. , 1990, The New England journal of medicine.

[22]  P. Drings.  European experience with ifosfamide in non-small cell lung cancer. , 1989, Seminars in oncology.

[23]  E. Tan,et al.  Vinorelbine, ifosfamide and cisplatin in advanced non-small cell lung cancer. , 1999, Acta oncologica.

[24]  R. Gralla,et al.  Vinorelbine (Navelbine) in the treatment of non-small-cell lung cancer: studies with single-agent therapy and in combination with cisplatin. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  R. Arriagada,et al.  Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma. , 1992, Journal of the National Cancer Institute.